Analysis Report

Finding 1: Patients in Treatment A had the lowest cardiovascular disease rate (31.9%).
Finding 2: Patients in Treatment A had the highest number of adverse events (628).
Finding 3: Patients in Treatment B had the highest adherence rate (61.1%).